Wiebe E, Hoff P, Buttgereit F
Z Rheumatol. 2025; 84(2):113-120.
PMID: 39976713
DOI: 10.1007/s00393-025-01620-4.
You X, Yan J, Herzog J, Nobakhti S, Campbell R, Hoke A
Bone Res. 2024; 12(1):65.
PMID: 39523344
PMC: 11551211.
DOI: 10.1038/s41413-024-00366-0.
Chincholi A, Cooper A, Mullally J
AACE Clin Case Rep. 2024; 10(5):170-173.
PMID: 39372831
PMC: 11447537.
DOI: 10.1016/j.aace.2024.05.001.
Kimura S, Sunouchi T, Watanabe S, Hoshino Y, Hidaka N, Kato H
Osteoporos Int. 2024; 35(9):1633-1643.
PMID: 38951164
PMC: 11364693.
DOI: 10.1007/s00198-024-07168-4.
Qiu S, Dhaliwal R, Divine G, Warner E, Rao S
J Bone Miner Res. 2024; 39(4):417-424.
PMID: 38477744
PMC: 11262150.
DOI: 10.1093/jbmr/zjae018.
Bisphosphonate-Related Atypical Femoral Fractures in Patients with Autoimmune Disease Treated with Glucocorticoids: Surgical Results for 20 Limbs.
Nishino T, Hyodo K, Matsumoto Y, Yanagisawa Y, Yamazaki M
J Clin Med. 2024; 13(4).
PMID: 38398341
PMC: 10889292.
DOI: 10.3390/jcm13041027.
Factors Affecting the Second Complete Atypical Femoral Fracture after the First Atypical Fracture.
Tsuchie H, Kasukawa Y, Nozaka K, Kinoshita H, Sasaki K, Aizawa T
Med Princ Pract. 2023; 33(1):10-20.
PMID: 38104544
PMC: 10896619.
DOI: 10.1159/000535759.
Persistent Bilateral Atypical Femoral Fractures in an Antiresorptive-Naïve Singaporean Chinese Patient with Graves' Disease.
Choo K, Dacay L, Chong L, Gani L
J ASEAN Fed Endocr Soc. 2023; 38(2):135-140.
PMID: 38045669
PMC: 10692435.
DOI: 10.15605/jafes.038.02.17.
Atypical femur fracture associated with common anti-osteoporosis drugs in FDA adverse event reporting system.
Xiao Y, Chen Y, Huang Y, Xiao Y
Sci Rep. 2023; 13(1):10892.
PMID: 37407650
PMC: 10322871.
DOI: 10.1038/s41598-023-37944-x.
Approach to the Patient With Bone Fracture: Making the First Fracture the Last.
Wang M, Seibel M
J Clin Endocrinol Metab. 2023; 108(12):3345-3352.
PMID: 37290052
PMC: 10655538.
DOI: 10.1210/clinem/dgad345.
Rechallenge of denosumab in advanced giant cell tumor of the bone after atypical femur fracture: A case report and review of literature.
Nasca V, Frezza A, Morosi C, Buonomenna C, Parafioriti A, Zappala G
Front Oncol. 2022; 12:953149.
PMID: 35928864
PMC: 9343706.
DOI: 10.3389/fonc.2022.953149.
Bisphosphonate Drug Holidays: Evidence From Clinical Trials and Real-World Studies.
Wang M, Wu Y, Girgis C
JBMR Plus. 2022; 6(6):e10629.
PMID: 35720669
PMC: 9189912.
DOI: 10.1002/jbm4.10629.
Atypical Femoral Fracture in a Patient without Bisphosphonate or Denosumab Exposure-A Case Report.
Georgiadis G, Begkas D, Maniatis K, Vasilakis A, Chatzopoulos S, Balanika A
J Orthop Case Rep. 2022; 11(10):21-24.
PMID: 35415098
PMC: 8930293.
DOI: 10.13107/jocr.2021.v11.i10.2450.
Evaluation of the Nature and Etiologies of Risk Factors for Diaphyseal Atypical Femoral Fractures.
Tsuchie H, Miyakoshi N, Kasukawa Y, Nozaka K, Saito K, Kinoshita H
Med Princ Pract. 2021; 30(5):430-436.
PMID: 34058735
PMC: 8562049.
DOI: 10.1159/000517484.
Post-operative Rehabilitation of Atypical Femoral Fracture in a Single Center.
Mizutani Y, Horiuchi H, Nakamura Y, Mochizuki M, Kotoda Y, Toyata T
Prog Rehabil Med. 2020; 5:20200007.
PMID: 32789275
PMC: 7369319.
DOI: 10.2490/prm.20200007.
In vitro effects of alendronate on fibroblasts of the human rotator cuff tendon.
Sung C, Kim R, Hah Y, Gwark J, Park H
BMC Musculoskelet Disord. 2020; 21(1):19.
PMID: 31926548
PMC: 6955091.
DOI: 10.1186/s12891-019-3014-1.
High bisphosphonate treatment rates and the prevalence of atypical femoral fractures in patients with systematic lupus erythematosus: a single-center retrospective study performed in Japan.
Sato H, Kondo N, Wakamatsu A, Kobayashi D, Nakatsue T, Wada Y
Rheumatol Int. 2019; 39(10):1803-1810.
PMID: 31385078
DOI: 10.1007/s00296-019-04407-4.
Antiresorptive-associated spontaneous fractures of both tibiae, followed by an atypical femur fracture during the sequential treatment with alendronate, denosumab then teriparatide.
Tan J, Sano H, Poole K
BMJ Case Rep. 2019; 12(7).
PMID: 31340943
PMC: 6663157.
DOI: 10.1136/bcr-2019-229366.
Bilateral subtrochanteric femur insufficiency fractures after bariatric surgery: a case report.
Nypaver C, Bernstein J, Mehta S
Osteoporos Int. 2019; 30(6):1317-1320.
PMID: 30976889
DOI: 10.1007/s00198-019-04956-1.
Combination therapy with BMP-2 and psoralen enhances fracture healing in ovariectomized mice.
Huang K, Wu G, Zou J, Peng S
Exp Ther Med. 2018; 16(3):1655-1662.
PMID: 30186384
PMC: 6122261.
DOI: 10.3892/etm.2018.6353.
